H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.
Pharmaceutical company Lundbeck will acquire Nasdaq-listed Longboard Pharmaceutical in a $2.6 billion deal, the two companies ...
Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share ...
Analyst Joon Lee of Truist Financial maintained a Buy rating on Longboard Pharmaceuticals (LBPH – Research Report), retaining the price ...
(Reuters) -H Lundbeck A/S has agreed to buy U.S.-based Longboard Pharmaceuticals for $2.6 billion, marking the biggest deal ...
The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals in a deal worth $2.6 billion ...
Danish pharmaceutical company Lundbeck will buy Longboard Pharmaceuticals (LBPH) in a deal valued at $2.6 billion, with the ...
Shares of Longboard Pharmaceuticals, Inc. (LBPH) were surging more than 50 percent in pre-market on Monday on the news of it being ...
智通财经APP获悉,丹麦制药巨头Lundbeck表示将以26亿美元的股权价值收购Longboard Pharmaceuticals ...
Longboard Pharmaceuticals Inc.的股价已达到令人印象深刻的里程碑,创下58.92美元的历史新高。这一峰值反映了投资者信心的显著增强,从公司673.36%的一年涨幅可见一斑。制药行业一直密切关注Longboard ...
周一,尽管目标价从45美元上调至60美元,B.Riley分析师仍将Longboard Pharmaceuticals Inc (NASDAQ:LBPH)的评级从买入下调至中性。这一调整是在Longboard宣布与Lundbeck达成约26亿美元的收购协议后做出的,收购价格相当于每股60美元。这一收购价格较Longboard截至2024年9月30日的30天成交量加权平均股价溢价77%。 Longbo ...
两家公司周一表示,Lundbeck将以每股60美元的现金收购Longboard,较Longboard上周五38.90美元的收盘价溢价54%。此外,两家公司表示,该交易预计于今年年底完成,扣除Longboard现金后的价值约为25亿美元。